131 related articles for article (PubMed ID: 8822750)
1. Should the presence of other diseases exclude subjects as controls in studies of gallbladder response to cholecystokinin octapeptide (sincalide)? Scintigraphic results in patients with malignancies but no known gallbladder disease.
Jacobson AF; Teefey SA
Nucl Med Commun; 1996 Jun; 17(6):514-9. PubMed ID: 8822750
[TBL] [Abstract][Full Text] [Related]
2. Sincalide-stimulated cholescintigraphy: a multicenter investigation to determine optimal infusion methodology and gallbladder ejection fraction normal values.
Ziessman HA; Tulchinsky M; Lavely WC; Gaughan JP; Allen TW; Maru A; Parkman HP; Maurer AH
J Nucl Med; 2010 Feb; 51(2):277-81. PubMed ID: 20080900
[TBL] [Abstract][Full Text] [Related]
3. Estimation of gallbladder ejection fraction utilizing cholecystokinin-stimulated magnetic resonance cholangiography and comparison with hepatobiliary scintigraphy.
Vyas PK; Vesy TL; Konez O; Ciavellara DP; Hua K; Gaisie G
J Magn Reson Imaging; 2002 Jan; 15(1):75-81. PubMed ID: 11793460
[TBL] [Abstract][Full Text] [Related]
4. Gallbladder response to a second dose of cholecystokinin during the same imaging study.
Sostre S; Canto MI; Kalloo AN
Eur J Nucl Med; 1992; 19(11):964-5. PubMed ID: 1425784
[TBL] [Abstract][Full Text] [Related]
5. Normal values for sincalide cholescintigraphy: comparison of two methods.
Ziessman HA; Muenz LR; Agarwal AK; ZaZa AA
Radiology; 2001 Nov; 221(2):404-10. PubMed ID: 11687683
[TBL] [Abstract][Full Text] [Related]
6. Liquid gastric emptying as an adjunct to hepatobiliary scintigraphy when oral corn oil is used as a cholecystagogue for determining gallbladder emptying.
Ponto JA
J Nucl Med Technol; 2015 Jun; 43(2):117-21. PubMed ID: 25857418
[TBL] [Abstract][Full Text] [Related]
7. Compounded versus proprietary sincalide for evaluation of gallbladder ejection fraction.
Guarasci DT; Trinh LH; Baeumler GR; Bednarczyk EM
Ann Pharmacother; 2004 Mar; 38(3):428-32. PubMed ID: 14755063
[TBL] [Abstract][Full Text] [Related]
8. Calculation of a gallbladder ejection fraction: advantage of continuous sincalide infusion over the three-minute infusion method.
Ziessman HA; Fahey FH; Hixson DJ
J Nucl Med; 1992 Apr; 33(4):537-41. PubMed ID: 1552338
[TBL] [Abstract][Full Text] [Related]
9. Poor Reproducibility of Gallbladder Ejection Fraction by Biliary Scintigraphy for Diagnosis of Biliary Dyskinesia.
Rose JB; Fields RC; Strasberg SM
J Am Coll Surg; 2018 Feb; 226(2):155-159. PubMed ID: 29157795
[TBL] [Abstract][Full Text] [Related]
10. Characterization of basal hepatic bile flow and the effects of intravenous cholecystokinin on the liver, sphincter, and gallbladder in patients with sphincter of Oddi spasm.
Krishnamurthy GT; Krishnamurthy S; Watson RD
Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):85-93. PubMed ID: 14574515
[TBL] [Abstract][Full Text] [Related]
11. Cholecystokinin cholescintigraphy: victim of its own success?
Ziessman HA
J Nucl Med; 1999 Dec; 40(12):2038-42. PubMed ID: 10616884
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of BD relied in great measure on gallbladder ejection fraction (GBEF) after sincalide stimulation on hepatobiliary scintigraphy.
Tulchinsky M
J Pediatr Surg; 2009 Oct; 44(10):2059; author reply 2059-60. PubMed ID: 19853777
[No Abstract] [Full Text] [Related]
13. Comparison of sonography and scintigraphy in the evaluation of gallbladder functional studies with cholecystokinin.
Barr RG; Kido T; Grajo JR
J Ultrasound Med; 2009 Sep; 28(9):1143-7. PubMed ID: 19710211
[TBL] [Abstract][Full Text] [Related]
14. Filling, postcholecystokinin emptying, and refilling of normal gallbladder: effects of two different doses of CCK on refilling: concise communication.
Mesgarzadeh M; Krishnamurthy GT; Bobba VR; Langrell K
J Nucl Med; 1983 Aug; 24(8):666-71. PubMed ID: 6308188
[TBL] [Abstract][Full Text] [Related]
15. Cholecystokinin cholescintigraphy: methodology and normal values using a lactose-free fatty-meal food supplement.
Ziessman HA; Jones DA; Muenz LR; Agarval AK
J Nucl Med; 2003 Aug; 44(8):1263-6. PubMed ID: 12902416
[TBL] [Abstract][Full Text] [Related]
16. Gallbladder ejection fraction: correlation of scintigraphic and ultrasonographic techniques.
Siegel A; Kuhn JC; Crow H; Holtzman S
Clin Nucl Med; 2000 Jan; 25(1):1-6. PubMed ID: 10634521
[TBL] [Abstract][Full Text] [Related]
17. Utilizing the Cholecystagogue, Ensure Plus, Results in Similar Hepatobiliary Scintigraphy Study Results and Patient Outcomes Status Post Cholecystectomy, in Comparison With Sincalide.
Peacock JG; Katchen JM; Christensen CT; Banks KP
Clin Nucl Med; 2020 Jan; 45(1):1-6. PubMed ID: 31789906
[TBL] [Abstract][Full Text] [Related]
18. Comparison of intravenous and intramuscular sincalide (C-terminal octapeptide of cholecystokinin) on gallbladder contraction in man.
Lalyre Y; Wilson DE; Kidao J; Hall CH; Capek V
Dig Dis Sci; 1981 Mar; 26(3):214-7. PubMed ID: 6263565
[TBL] [Abstract][Full Text] [Related]
19. Sincalide cholescintigraphy--32 years later: evidence-based data on its clinical utility and infusion methodology.
Ziessman HA
Semin Nucl Med; 2012 Mar; 42(2):79-83. PubMed ID: 22293163
[TBL] [Abstract][Full Text] [Related]
20. Sincalide-Stimulated Cholescintigraphy: A Retrospective Study and Proposal of a Modified Workflow.
Vasireddi A; Nguyen NC
Clin Nucl Med; 2022 Jan; 47(1):1-6. PubMed ID: 34874343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
